Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab175576 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Lenzilumab (anti-GM-CSF)
- Antibody type
- Recombinant
- Description
- Lenzilumab (anti-GM-CSF) is a humanized monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies.
- Reactivity
- Human
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Lenzilumab (anti-GM-CSF) (Ab175576) - ELISA Immobilized Recombinant Human GM-CSF Protein (rp146523) at 0.3 μg/mL can bind Lenzilumab (anti-GM-CSF) (Ab175576) with the EC₅₀ of 37.91 ng/mL.
